TLSA

Dr Howard Weiner, Chairman of the Tiziana Scientific Advisory Board, to give an interview on Bloomberg Markets at 1.50pm ET today

Tiziana Life Sciences plc (the "Company") Result of Annual General Meeting

TLSA Stock Price Increases Over 6% Pre-Market: Why It Happened

Tiziana Life Sciences pulls the trigger on phase II Covid trial after appointing a contract research group

Tiziana Enters a Collaboration Agreement with FHI Clinical to Conduct a Phase 2 Clinical Trial for Treating Hospitalized Severe COVID-19 Patients with Intranasal Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody

Tiziana Life Sciences appoints head of regulatory affairs

Tiziana Appoints Dr. Kevin Schutz as Vice-President of Regulatory Affairs